A cell-based screen identifies HDAC inhibitors as activators of RIG-I signaling
E. Fraile-Bethencourt, M. H. Foss, D. Nelson, S. V. Malhotra, S. Anand
The paper identifies HDAC inhibitors as activators of RIG-I signaling through a cell-based screen and shows their potential in enhancing immune responses in cancer.
bioRxiv · Sep 28, 2021Cancer Biology